Maia, Manuel Caitano
Salgia, Meghan
Pal, Sumanta K.
Article History
Accepted: 17 February 2020
First Online: 17 March 2020
Competing interests
: M.C.M. has received speaker’s fees from Pfizer, Astellas, AstraZeneca and BMS, educational meeting sponsorship from Astellas, Jansen, BMS, Libbs, Roche, Ipsen, MSD, Novartis and Bayer, and consulting fees from AstraZeneca and MSD. S.K.P. has received consulting fees from Genentech, Aveo, Eisai, Roche, Pfizer, Novartis, Exelixis, Ipsen, BMS and Astellas. M.S. declares no competing interests.